Perioperative management of a patient with PEHO - Syndrome : Delayed recovery of neuromuscular blockade after rocuronium
نویسندگان
چکیده
The PEHO syndrome (progressive encephalopathy with brain, facial and peripheral edema, hypsarrhythmia and optic atrophy) is a very rare autosomal recessive disorder with progressive encephalopathy. For diagnosis and therapy, many patients may require deep sedation or even general anesthesia. There are no previous reports on the perioperative management in PEHO-patients. Distinct obstacles have to be obeyed. Lack of pharyngeal control might bear an imminent risk of aspiration. Muscular hypotonia and an immobile state rules out the use of succinylcholine. In the case reported here, a 10-month old boy underwent laparoscopic assisted percutaneous jejunostomy. The anesthetic management consisted of total intravenous anesthesia with propofol and remifentanil, preceded by a rapid sequence induction with 0.6 mg/kg rocuronium. In our patient, recovery from neuromuscular blockade was grossly delayed. Therefore, with all applications of neuromuscular blocking agents in patients with PEHO-syndrome, continuous neuromuscular monitoring is indispensable even on the intensive care unit to determine the end of the neuromuscular block and to exclude residual curarisation. Anestesia Pediatrica e Neonatale, Vol. 8, N. 1, Febbraio-Marzo 2010
منابع مشابه
Delayed recovery from rocuronium block in an infant.
Prolonged duration of action of rocuronium in an infant patient is rare. We report an unusual case of prolonged neuromuscular blockade with rocuronium in an infant undergoing cleft lip repair anesthetized with sevoflurane and management of the patient.
متن کاملEarly and late reversal of rocuronium and vecuronium with neostigmine in adults and children.
UNLABELLED We investigated the influence of the timing of neostigmine administration on recovery from rocuronium or vecuronium neuromuscular blockade. Eighty adults and 80 children were randomized to receive 0.45 mg/kg rocuronium or 0.075 mg/kg vecuronium during propofol/fentanyl/N2O anesthesia. Neuromuscular blockade was monitored by train-of-four (TOF) stimulation and adductor pollicis electr...
متن کاملRocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy
INTRODUCTION Anesthetic management of patients with Duchenne muscular dystrophy (DMD) is complicated because these patients are more sensitive to nondepolarizing neuromuscular blocking agents (NMBAs) and are vulnerable to postoperative complications, such as postoperative residual curarization and respiratory failure. Sugammadex is a new reversal agent for aminosteroidal NMBAs, but its safety i...
متن کاملUpdate on the management of neuromuscular block: focus on sugammadex
Steroidal neuromuscular blocking agents (NMBAs), such as rocuronium, are widely used in clinical anesthesia and emergency medicine to facilitate endotracheal intubation and artificial ventilation and to allow surgical access to body cavities. Reversal of neuromuscular blockade is important for the acceleration of patient recovery and prevention of postoperative residual neuromuscular blockade a...
متن کاملSensitivity to Rocuronium-Induced Neuromuscular Block and Reversibility with Sugammadex in a Patient with Myotonic Dystrophy
We report a patient with myotonic dystrophy who showed prolonged rocuronium-induced neuromuscular blockade, although with a fast recovery with sugammadex. During general anesthesia with propofol and remifentanil, the times to spontaneous recovery of the first twitch (T1) of train of four to 10% of control values after an intubating dose of rocuronium 1 mg/kg and an additional dose of 0.2 mg/kg ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2010